We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App





Abbott Demonstrates End to End Laboratory Solutions

By LabMedica International staff writers
Posted on 31 Jul 2024

Abbott (Abbott Park, IL, USA) is returning to the ADLM Clinical Lab Expo (formerly AACC) in 2024 with new product launches, workshops, and live demonstrations at the show. More...

Abbott’s next-generation Alinity systems are taking center stage at ADLM 2024. The Alinity family is harmonized across key laboratory disciplines, streamlining critical interactions between individuals, systems, and information, and enabling labs to redefine performance. Abbott is demonstrating the Alinity ci-series of integrated clinical chemistry & immunoassay systems offering powerful integration across clinical chemistry and immunoassay. These systems can easily scale, combining up to four modules in multiple configurations to meet any laboratory's needs and maximize its operational efficiency. The Alinity c compact clinical chemistry system maximizes testing throughput with high-quality assays to deliver efficient and accurate performance. The Alinity I compact immunoassay system utilizes proven CHEMIFLEX chemiluminescent detection technology to provide greater confidence in results.

Abbott is also highlighting the Alinity h-series integrated hematology systems which deliver simplified workflows through an innovative design to streamline the hematology laboratory. The Alinity hq compact hematology system enables laboratories to run at maximum efficiency while the Alinity hs compact slidemaker stainer system for an automated workflow delivers consistency. Visitors to Abbott’s booth at ADLM 2024 can also experience the Alinity m fully integrated, automated, high-throughput molecular diagnostics analyzer with high-quality assays that delivers the next level of flexibility and efficiency to molecular labs. Also featuring at the show is Abbott’s award-winning i-STAT Alinity point-of-care system designed to be easy, accurate and connected, providing results in minutes and integrating diagnostic patient-testing directly into the clinical-care pathway.

Additionally, a Scientific Industry Workshop from Abbott led by an expert will focus on analytical and clinical aspects across high and low hs-cardiac troponin results, while covering factors that may lead to potential misdiagnosis of myocardial infarction. Abbott’s MED Talks and LAB Voice sessions will be 20-30 minute presentations covering a wide range of key topics impacting labs, physicians, and the healthcare space today. The presentations will offer attendees emerging details on research, findings, and outcomes.

Related Links:
Abbott


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.